日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients

抗血管生成治疗的替代标志物和贝伐单抗联合放疗和化疗的剂量限制性毒性:直肠癌患者 I 期试验的持续经验

Christopher G Willett, Yves Boucher, Dan G Duda, Emmanuelle di Tomaso, Lance L Munn, Ricky T Tong, Sergey V Kozin, Lucine Petit, Rakesh K Jain, Daniel C Chung, Dushyant V Sahani, Sanjeeva P Kalva, Kenneth S Cohen, David T Scadden, Alan J Fischman, Jeffrey W Clark, David P Ryan, Andrew X Zhu, Lawrenc

Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma

贝伐单抗、奥沙利铂和吉西他滨治疗复发性苗勒氏管癌的 II 期研究的安全性、有效性和生物标志物探索

Neil S Horowitz, Richard T Penson, Dan G Duda, Emmanuelle di Tomaso, Yves Boucher, Marek Ancukiewicz, Kenneth S Cohen, Suzanne Berlin, Carolyn N Krasner, Marsha A Moses, Rakesh K Jain

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma

西地尼布(一种口服全血管内皮生长因子受体酪氨酸激酶抑制剂)治疗复发性胶质母细胞瘤患者的 II 期研究

Tracy T Batchelor, Dan G Duda, Emmanuelle di Tomaso, Marek Ancukiewicz, Scott R Plotkin, Elizabeth Gerstner, April F Eichler, Jan Drappatz, Fred H Hochberg, Thomas Benner, David N Louis, Kenneth S Cohen, Houng Chea, Alexis Exarhopoulos, Jay S Loeffler, Marsha A Moses, Percy Ivy, A Gregory Sorensen, 

Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy

阻断肿瘤相关巨噬细胞中的肿瘤坏死因子 α 信号作为放射增敏策略

Yuru Meng, Michael A Beckett, Hua Liang, Helena J Mauceri, Nico van Rooijen, Kenneth S Cohen, Ralph R Weichselbaum

A protocol for phenotypic detection and characterization of vascular cells of different origins in a lung neovascularization model in rodents

啮齿动物肺新生血管模型中不同来源血管细胞的表型检测和表征方案

Rosemary C Jones, Diane E Capen, Kenneth S Cohen, Lance L Munn, Rakesh K Jain, Dan G Duda

Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics

正常卵巢表面上皮标记保留细胞表现出干细胞/祖细胞特征

Paul P Szotek, Henry L Chang, Kristen Brennand, Akihiro Fujino, Rafael Pieretti-Vanmarcke, Cristina Lo Celso, David Dombkowski, Frederic Preffer, Kenneth S Cohen, Jose Teixeira, Patricia K Donahoe

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients

AZD2171 是一种泛 VEGF 受体酪氨酸激酶抑制剂,可使胶质母细胞瘤患者的肿瘤血管正常化并减轻水肿

Tracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, Wei-Ting Zhang, Dan G Duda, Kenneth S Cohen, Kevin R Kozak, Daniel P Cahill, Poe-Jou Chen, Mingwang Zhu, Marek Ancukiewicz, Maciej M Mrugala, Scott Plotkin, Jan Drappatz, David N Louis, Percy Ivy, David T Scadden, Thomas Benner, Jay S Loef

A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood

人类血液中循环内皮细胞和循环祖细胞的表型检测和计数方案

Dan G Duda, Kenneth S Cohen, David T Scadden, Rakesh K Jain